Duration of symptoms and plasma cytokine levels in patients with the common cold treated with zinc acetate: A randomized, double-blind, placebo-controlled trial

Annals of Internal Medicine

Volumn 133, Issue 4, 2000, Pages 245-252

  Prasad, A S ^a   Fitzgerald, J T ^a   Bao, B ^a   Beck, F W J ^a   Chandrasekar, P H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ZINC ACETATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMMON COLD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0034663423     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-133-4-200008150-00006     Document Type: Article

References (37)

1. Rhinovirus infections in an industrial population. I. The occurrence of illness
2. The common cold: Control?
3. Reduction in duration of common cold by zinc gluconate lozenges in a double-blind study
4. Prophylaxis and treatment of rhinovirus colds with zinc gluconate lozenges
5. Zinc gluconate and the common cold: A controlled clinical study
6. Zinc gluconate lozenges for treating the common cold. A randomized, double-blind, placebo-controlled study
7. Randomized, double-masked, placebo-controlled clinical study of the effectiveness of zinc acetate lozenges on common cold symptoms in allergy-tested subjects
8. Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus cold
9. Failure of effervescent zinc acetate lozenges to alter the course of upper respiratory tract infection of Australian adults
10. Failure of zinc gluconate in treatment of acute upper respiratory tract infections
11. Zinc gluconate lozenges for common cold. A double-blind clinical trial
12. Zinc gluconate lozenges for treating common cold in children
13. Linearity in dose-response from zinc lozenges in treatment of common colds
14. Inhibition by zinc of rhinovirus protein cleavage: Interaction of zinc with capsid polypeptides
15. Going back to the future with small synthetic compounds
16. How does zinc modify the common cold? Clinical observations and implications regarding mechanism of action
17. Improving the quality of repotting of randomized controlled trials. The CONSORT statement
18. Techniques for measurement of zinc in biological samples
19. Metal ion-FTS nonapeptide interactions. A quantitative study of zinc(II)-nonapeptide complexes (thymulin) under physiological conditions and assessment of their biological significance
20. Zinc gluconate lozenges for treating the common cold
21. Where's the bias?
22. A meta-analysis of zinc salts lozenges and the common cold
23. In vitro activity of zinc salts against human rhinoviruses
24. Cytokine antagonists in aged subjects and their relation withcellular immunity
25. Neopterin as a marker for activated cell-mediated immunity: Application in HIV infection
26. Cytokine antagonists in infections and inflammatory disorders
27. Interleukin 1 receptor antagonist. A new member of interleukin 1 family
28. Cytokines in rheumatoid arthritis
29. Zinc status and interleukin-1 β-induced alterations in mineral metabolism in rats
30. Role of growth factors in inflammation and repair
31. What's new with common colds? Pathogenesis and diagnosis
32. Nasal cytokine production in viral acute upper respiratory infections of childhood
33. Human major group rhinoviruses downmodulate the accessory function of monocytes by inducing IL-10
34. Changes in cytokines production and T cell subpopulations in experimentally induced zinc-deficient humans
35. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: A randomized clinical trial
36. Interactions of zinc with other micronutrients